Cargando...
Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief Report
We examined whether neuropsychiatric symptoms (NPS) interact with cerebrospinal fluid (CSF) biomarkers (amyloid-β(42) [Aβ(42)], tau, phosphorylated tau(181) [ptau(181)], tau/Aβ(42), and ptau(181)/Aβ(42)) of Alzheimer's disease pathology to predict driving decline among cognitively-normal older...
Guardado en:
| Publicado en: | J Alzheimers Dis |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5555740/ https://ncbi.nlm.nih.gov/pubmed/28453487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-170067 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|